Trials / Completed
CompletedNCT02712593
A Study Investigating the Effects of Niagen™ in Healthy Adults.
A Randomized, Double-blind, Placebo Controlled Parallel Study Investigating the Effects of Niagen™ (Nicotinamide Riboside) on Niagen™ Metabolites in Healthy Adults.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- KGK Science Inc. · Industry
- Sex
- All
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the effect of repeated doses of Niagen™ on Niagen™ metabolite concentrations in blood, urine and muscle. There will be 3 doses of Niagen™ compared to a placebo. One quarter of subjects will receive the low dose of Niagen™, one quarter will receive the moderate dose of Niagen™, one quarter will receive the higher dose of Niagen™ and one quarter will reveive the placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Niagen™ 100 | |
| DIETARY_SUPPLEMENT | Niagen™ 300 | |
| DIETARY_SUPPLEMENT | Niagen™ 1000 | |
| OTHER | Placebo |
Timeline
- Start date
- 2016-03-21
- Primary completion
- 2017-03-17
- Completion
- 2017-04-01
- First posted
- 2016-03-18
- Last updated
- 2018-04-11
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02712593. Inclusion in this directory is not an endorsement.